Astragalus for Blood Sugar Regulation

Research suggests that Astragalus and its primary active compounds — particularly astragalus polysaccharide (APS) and astragaloside IV (AS-IV) — may support blood sugar regulation through multiple biological pathways, including improvements in insulin sensitivity, reduction of oxidative stress, modulation of gut microbiota, and protection of tissues commonly damaged by diabetes, such as the kidneys and pancreas. Studies indicate that these effects involve molecular mechanisms such as autophagy promotion, SIRT1 pathway activation, and suppression of inflammation-related signaling, with several animal studies also suggesting that Astragalus combinations with other herbs or probiotics may produce stronger effects than the herb used alone. The available evidence comes predominantly from animal studies, laboratory experiments, and narrative reviews, with very limited human clinical trial data represented in this body of research, meaning findings should be interpreted cautiously and cannot be directly extrapolated to humans. Two studies in this set were directionally neutral, focusing on related but distinct applications such as cancer-related fatigue and stroke recovery, and while the overall research direction is supportive, the absence of robust randomized controlled trials in humans remains a significant limitation for drawing firm conclusions about Astragalus as a blood sugar intervention.